Commercial Sales Network v. Sadler-Cisar, Inc.

755 F. Supp. 756, 1991 U.S. Dist. LEXIS 1314, 1991 WL 12394
CourtDistrict Court, N.D. Ohio
DecidedJanuary 2, 1991
Docket5:90 CV 1549
StatusPublished
Cited by1 cases

This text of 755 F. Supp. 756 (Commercial Sales Network v. Sadler-Cisar, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Commercial Sales Network v. Sadler-Cisar, Inc., 755 F. Supp. 756, 1991 U.S. Dist. LEXIS 1314, 1991 WL 12394 (N.D. Ohio 1991).

Opinion

ORDER

BATTISTI, District Judge.

Before the court is Plaintiff Commercial Sales Network’s (“CSN”) motion to remand the instant case to the Summit County Court of Common Pleas and to order Defendants’ to pay Plaintiff’s costs and attorney’s fees. For the reasons stated herein, the motion to remand is GRANTED, and the motion for costs and fees is DENIED.

I. STATEMENT OF FACTS

This case arises out of a licensing agreement between CSN and Defendant Sadler-Cisar, Inc. (“SCI”), entered into on August II, 1989 (the “Agreement”). The Agreement provided that SCI would use CSN “as the exclusive sales force and production agency to sell and produce medi* dot and all related products.”

Medi dot is described in Defendants’ Notice of Removal as an “Event Reminder Device.” Essentially, medi* dot is an adhesive label with scratch-off dots. The product’s user is supposed to affix the label to a medication container and scratch off a dot each time the medication is taken. Medi* dot is meant to aid people in remembering whether they’ve taken their medication, and is the subject of U.S. Patent No. 4,830,407 (the “Medi* dot patent”).

On August 21,1990, CSN filed suit in the Summit County Court of Common Pleas (Case No. CV-90-08-2832), alleging that SCI had breached the Agreement. CSN claimed that SCI attempted to rescind the Agreement on or about July 12, 1990, and subsequently, had “contacted manufacturers, sales representatives and other existing active accounts ... through [Defendant] Medi-Dot, Inc.” See Plaintiff’s Complaint, at 11 5. Medi-Dot, Inc. is a corporation which has allegedly been granted a superseding exclusive license to market and sell medi* dot.

CSN seeks compensatory damages for the breach, an injunction preventing SCI from initiating any further contact with any accounts related to medi* dot, and a declaratory judgement setting forth the rights and other legal relations of the parties under the Agreement.

On August 30, 1990, the Defendants removed the case to this court pursuant to 28 U.S.C. § 1441. Despite noting that “[o]n its face, Plaintiff’s complaint does not refer to patent, trademark and copyright infringement matters,” the Defendants allege that the “obvious underlying meaning of Plaintiff’s pleadings and discovery requests” were intimately related to patent, copyright and trademark claims that the Defendants plan to raise in federal court. 1 Defendants concluded by stating that the instant controversy falls within the original and exclusive jurisdiction of this court be *758 cause it involves “issues of patent and trademark infringement.”

The motion to remand currently before the court was filed on September 27, 1990, and the Defendants responded on October 9, 1990. The arguments presented by both the Plaintiff and the Defendants in their briefs were exceedingly thin in substance, and inexplicably missed the major issues implicated by the motion to remand. A federal district court, however, is explicitly authorized to remand a case on its own initiative when it determines that subject matter jurisdiction is lacking. 28 U.S.C. § 1447(c).

II. DISCUSSION

A. SUBJECT MATTER JURISDICTION

Section 1441(a) of Title 28, United States Code, provides for the removal from state court of civil actions of which federal district courts have original jurisdiction. Although the Defendants have failed to identify the proper source of jurisdiction in their notice of removal, it is clear that they rely upon 28 U.S.C. § 1338(a), which provides:

The district courts shall have original jurisdiction of any civil action arising under any Act of Congress relating to patents, plant variety protection, copyrights and trade-marks. Such jurisdiction shall be exclusive of the courts of the states in patent, plant variety protection and copyright cases.

In the instant case, the Defendants bear the burden of establishing that Plaintiffs claims “arise under” the federal patent, copyright and trademark laws. See Wilson v. Republic Iron & Steel Co., 257 U.S. 92, 97, 42 S.Ct. 35, 37, 66 L.Ed. 144 (1921); see also 14A C. Wright, A. Miller & E. Cooper, Federal Practice and Procedure § 3721, at 209-10 (2d ed. 1985). Section 1441 must at all times be strictly construed out of regard for the “rightful independence” of state courts. See Shamrock Oil & Gas Corp. v. Sheets, 313 U.S. 100, 108-09, 61 S.Ct. 868, 872, 85 L.Ed. 1214 (1941).

The Supreme Court of the United States considered the scope of § 1338 in Chris-tianson v. Colt Indus. Operating Corp., 486 U.S. 800, 108 S.Ct. 2166, 100 L.Ed.2d 811 (1988). In Christianson, the Court held that § 1338 jurisdiction extends “only to those cases in which a well-pleaded complaint establishes either that federal patent law creates the cause of action or that the plaintiff's right to relief necessarily depends on resolution of a substantial question of federal patent law, in that patent law is a necessary element of one of the well-pleaded claims.” Id. at 809, 108 S.Ct. at 2173.

It is clear in this case, as it was in Christianson, that federal patent law does not create Plaintiffs cause of action. Plaintiffs claims arise out of state contract law in that they explicitly assert allegations of breach and seek declarations of the present status of the Agreement and the relationship of the parties thereunder. Accordingly, it must be determined whether patent law is a necessary element of one of the Plaintiffs well-pleaded contract claims.

The Christianson Court notes that the fact that “a claim makes no reference to federal patent law does not necessarily mean the claim does not ‘arise under’ patent law.” Id. at 809 n. 3, 108 S.Ct. at 2174 n. 3. On the other hand, “a case raising a federal patent-law defense does not, for that reason alone, ‘arise under’ patent law, ‘even if the defense is anticipated in the plaintiff’s complaint, and even if both parties admit that the defense is the only question truly at issue in the case.’ ” Id. at 809, 108 S.Ct. at 2174 (quoting Franchise Tax Board of California v. Construction Laborers Vacation Trust, 463 U.S. 1, 14, 103 S.Ct. 2841, 2848, 77 L.Ed.2d 420 (1983)).

The Defendants claim that “this controversy embodies ... issues of patent and trademark infringement_” See Defendants’ Notice of Removal, at 4.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Sadler-Cisar, Inc. v. Commercial Sales Network, Inc.
786 F. Supp. 1287 (N.D. Ohio, 1991)

Cite This Page — Counsel Stack

Bluebook (online)
755 F. Supp. 756, 1991 U.S. Dist. LEXIS 1314, 1991 WL 12394, Counsel Stack Legal Research, https://law.counselstack.com/opinion/commercial-sales-network-v-sadler-cisar-inc-ohnd-1991.